Eris Lifesciences Limited — Call Transcript 2021

Jul 22, 2021

==> picture [596 x 69] intentionally omitted <==

==> picture [596 x 69] intentionally omitted <==

Date: 22[nd] July, 2021

To	To
BSE Limited	National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers	Exchange Plaza
Dalal Street	Bandra Kurla Complex
Mumbai- 400001	Bandra (E)
	Mumbai-400051
Security Code: 540596	Symbol: ERIS

SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (SEBI LODR, 2015)

Dear Sir/Madam,

This is further to our letter dated 21[st] July, 2021 intimating about the date of the Board of Directors Meeting to inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended 30[th] June, 2021.

We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI LODR, 2015 the Company will hold a conference call for analysts and investors on Thursday, 29[th] July, 2021. The details of the said call are attached herewith and also available on Company’s website.

Thanking you.

For Eris Lifesciences Limited

_______ Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493

Encl.:a/a

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 5] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [101 x 58] intentionally omitted <==

The Senior Management Team of

Eris Lifesciences Limited

Cordially invites you to its

Earnings Conference Call

To discuss the financial and operational performance for

Q1 FY22

Day/Date: Thursday, 29[th] July, 2021

Time: 4:00 PM, IST

Option 1: Express Join with Diamond Pass[TM]

 Pre-register with the below link and join without waiting for the operator:

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9082501&linkSecurityString=20cfbae50c

Option 2: Join through below Dial-In Numbers

Access Numbers

Primary Number:

+91 22 6280 1472 +91 22 7115 8839

USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 Argentina: 008 001 424 3444 Australia: 180 005 3698 Belgium: 008 001 424 3444 Canada: 0 118 001 424 3444 China: 400 842 8405 International Toll Free Number: France: 080 091 4745 Germany: 008 001 424 3444 Italy: 008 001 424 3444 Japan: 005 311 61110 Netherlands: 0 800 022 9808 Poland: 0 0800 112 4248 South Korea: 0 018 001 424 3444 Sweden: 008 001 424 3444 Switzerland: 080 056 1863 Thailand: 0 018 001 424 3444

We look forward to your participation

___________

RSVP:

Kruti Raval: +91 99090 17419